The Spanish Clinical Research Network (CAIBER) incorporates five clinical trials led by researchers at the IDIBELL to Plan Clinical Research after obtaining a favorable resolution and excellent grades in the 2010 Intramural call. IDIBELL projects
Five clinical trials led by IDIBELL will form part of the CAIBER Clinical Research Plan Read More »
IDIBELL has signed a collaboration agreement with the Foundation Step By Step, dedicated to the recovery of spinal injuries, to promote and support new research in the field of spinal cord injury. Step by Step
The Spanish Society of Genetics has rewarded the IDIBELL researcher in genetic applications category The Spanish Society of Genetics (SEG) and the Foundation Pryconsa have distinguished the contributions of the IDIBELL researcher, Manel Esteller, in the research on genetic application in the III Edition of the National Genetics Awards to be delivered under the XXXVIII SEG Congress, to be held from 21 to 23 September in Murcia. Manel Esteller Profile
Manel Esteller, National Genetics Award 2011 Read More »
The group of Metabolism and cellular signals at Biomedical Research Institute Alberto Sols led by Juan Manuel Zapata focuses its research on studying the regulation of TNF receptor, TRAF family of proteins and how changes in abnormal expression of these proteins may be involved in the development of leukemia or lymphoma. Zapata explained his progress in the last session of IDIBELL series of seminars held on July 8.
The year 2011 marks the International Year of Women Scientists just one hundred years after it was first awarded a Nobel Prize to a scientist, Marie Curie. In this context, on July 4 was held a meeting on the invisibility of female talent organized by ‘fem.talent’ project and Biopol’H. More information about the meeting: http://www.biopol.cat/cat/noticias/
The researcher and Professor of Nuclear Medicine at Rabdoud University, Nijmegen (Netherlands), Wim Oyen, explained its progress in the implementation of FDG/PET imaging technique to improve the diagnosis of various diseases and facilitate the process of therapeutic decision. It was on July 1st as part of the seminars IDIBELL.
Wim Oyen:”Getting the best diagnosis in the shortest time” Read More »
The research group of Joan X. Comella focuses on characterizing and understanding the molecular mechanisms of certain proteins that block cell death in the nervous system. This cell death is often associated with neuroinflammatory processes. “These proteins protect neurons from cell death,” explained Comella framed in a lecture in the series of seminars IDIBELL on 17 June.
The leader of the research group on Toxicity of sensory and motor systems at IDIBELL and Professor of Physiology at the University of Barcelona, Jordi Llorens has been named president of the International Neurotoxicology Association within the framework of the international neurotoxicology conference that the association has organized on June 5-10th in Xian, China. The
Jordi Llorens named president of the International Neurotoxicology Association Read More »
On 6 June the Institute for Bioengineering of Catalonia (IBEC) presented its activities to IDIBELL biomedical researchers, as part of the official agreement of collaboration between both institutes, in a conference organized by the Biopol’H.
IBEC presents its activities to IDIBELL researchers Read More »
The pediatrician and oncologist Manuel Ramírez explained at a conference in the past IDIBELL June 10 his clinical experience in children with solid tumors treated with the virus ICOVIR 5, designed by the research group on virotherapy of the IDIBELL led by Ramon Alemany, in the Unit of Pediatric Hematology and Oncology of the Hospital Niño Jesús in Madrid where he heads a research group for developing new therapies for children with cancer.
